-
1
Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients
Published 2019-01-01Subjects: Get full text
Article -
2
A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance”
Published 2025-01-01Subjects: “…Antirheumatic agents…”
Get full text
Article -
3
Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance
Published 2024-07-01Subjects: “…Antirheumatic agents…”
Get full text
Article -
4
-
5
Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
Published 2025-01-01Subjects: “…antirheumatic agents…”
Get full text
Article -
6
Psoriatic arthritis: A retrospective study of 162 patients
Published 2005-01-01Subjects: Get full text
Article